Selectivity and toxicity of antiarrhythmic drugs: Molecular interactions with ion channels

American Journal of Medicine

Volumn 104, Issue 2, 1998, Pages 179-195

  Katz, Arnold M ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; AMIODARONE; AMLODIPINE; ANTIARRHYTHMIC AGENT; ATENOLOL; BRETYLIUM; CALCIUM CHANNEL; DILTIAZEM; DISOPYRAMIDE; ENCAINIDE; FLECAINIDE; ION CHANNEL; LIDOCAINE; METOPROLOL; MEXILETINE; MORACIZINE; NIFEDIPINE; PHENYTOIN; POTASSIUM CHANNEL; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SODIUM CHANNEL; SOTALOL; TIMOLOL; TOCAINIDE; VERAPAMIL; VOLTAGE GATED CHANNEL FORMING PROTEIN;

ACTION POTENTIAL; ARRHYTHMOGENESIS; CELL MEMBRANE; CEREBROVASCULAR ACCIDENT; CHANNEL GATING; DEFIBRILLATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

EID: 0032004998     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00388-4     Document Type: Article

References (125)

1. 1. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function and time-dependence of risk Circulation. 1992;85(suppl I):1-2-1-10.
2. 2. Petersen P. Thromboembolic complications in atrial fibrillation. Stroke. 1990;21:4-13.
3. 3. Cairns JA, Connoly ST. Nonrheumatic atria fibrillation: risk of stroke and role of antithrombotic therapy. Circulation. 1991;84: 469-481.
4. 4. Cardiac Arrhythmia Suppression Trial Investigators. Preliminary report: effect of encaininde and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. NEJM. 1989;321:406-412.
5. 5. Katz AM. Physiology of the Heart. 2nd ed. New York: Raven Press; 1992.
6. 6. Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (Lond). 1952;117:500-544.
7. 7. Bean B. Calcium channels. Gating for the physiologist. Nature. 1990;348:192-193.
8. 8. Andersen OS, Keoppe RE, II. Molecular determinants of channel function. Physiol Rev. 1992;723:S89-S158.
9. 9. Stühmer W, Conti F, Suzuki H, et al. Structural parts involved in activation and inactivation of the sodium channel. Nature. 1989; 339:597-603.
10. 10. Catterall WA. Structure and function of voltage-sensitive ion channels. Science. 1988;242:50-61.
11. 11. Aldrich RW. Ion channels. Mutating and gating. Nature. 1989; 339:578-579.
12. 12. Hille B. Ionic Channels of Excitable Membranes. 2nd ed. Sunderland, Mass: Sinauaer; 1992.
13. 13. Cohen SA, Barchi RL. Cardiac sodium channel structure and function. Trends Cardiovasc Med. 1992;2:133-140.
14. 14. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev. 1992;72(suppl):S15-S48.
15. 15. Jan LY, Jan YN. Tracing the roots of ion channels. Cell. 1992;69: 715-718.
16. 16. Katz AM. Cardiac ion channels. NEJM. 1993;328:1244-1251.
17. 17. Katz AM. Calcium channel diversity in the cardiovascular system. J Am Coll Cardiol. 1996;28:522-529.
18. 18. Hartzell HC, Duchatelle-Gourdon I. Structure and neural modulation of cardiac calcium channels. J Cardiovasc Electrophys. 1992; 3:567-578.
19. 2+ channels due to phosphorylation by cAMP-dependent protein kinase. Nature. 1993;364:240-243.
20. 20. Hartzell HC, Hirayama Y, Petit-Jacques J. Effect of protein phosphatase and kinase inhibitors on the cardiac L-type Ca current suggest two sites are phosphorylated by protein kinase A and another protein kinase. J Gen Physiol. 1995;106:393-414.
21. 21. Murphy BJ, Rogers J, Perdichizzi AP, et al. CAMP-dependent phosphorylation of two sites in the α subunit of the cardiac sodium channel. J Biol Chem. 1996;271:28837-28843.
22. 22. Isom LL, Ragsdale DS, DeJongh KS, et al. Structure and function of the β2 subunit of brain sodium channels, a transmembrane protein with a CAM motif. Cell. 1995;83:433-442.
23. + channel subunits and ig domains. Nature. 1996;383:307-308.
24. 24. Nunoki K, Florio V, Catterall WA. Activation of purified calcium channels by stoichiometric protein phosphorylation. Proc Nat Acad Sci. 1989;86:6816-6820.
25. 25. Ruth P, Röhrkasten A, Biel M, et al. Primary structure of the β subunit of the DHP-sensitive calcium channel from skeletal muscle. Science. 1988;245:1115-1118.
26. + channel by mutation of the H5 region. Nature. 1991;341:700-704.
27. + channel. Science. 1991;251:939-942.
28. + channels. Science. 1991;251: 942-944.
29. 29. Cohen SA, Barchi RL. Cardiac sodium channel structure and function. Trends Cardiovasc Med. 1992;2:133-140.
30. 30. Tomaselli GF, Backx PH, Marban E. Molecular basis of ion permeation in voltage-gated ion channels. Circ Res. 1993;72:491-496.
31. 31. Noda M, Ikeda T, Kayano T, et al. Existence of distinct sodium channel messenger RNAs in rat brain. Nature. 1986;320:188-192.
32. + channel inactivation gating. Circ Res. 1994;75:114-122.
33. 33. Bennett PB, Valenzuela C, Chen L-Q, Kallen RG. Circ Res. 1995; 77:584-592.
34. + channel inactivation gate during inactivation. J Biol Chem. 1996; 271:30971-30979.
35. 35. Hoshi T, Zagotta WN, Aldrich RW. Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science. 1990;250:533-538.
36. + channel. Nature. 1991;353:86-90.
37. 37. Antz C, Geyer M, Fakler B, et al. NMR structure of inactivation gates from mammalian voltage-dependent potassium channels. Nature. 1997;385:272-274.
38. 38. Jan LY, Jan YN. Potassium channels and their evolving gates. Nature. 1994;371:119-122.
39. 39. Zagotta WN, Hoshi T, Aldrich RW. Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB. Science. 1990;250:568-571.
40. K (A) channels reopen during recovery from inactivation. Nature. 1991;353:657-660.
41. 41. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805-811.
42. 42. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683-685.
43. 43. Towbin JA. Clinical implications of basic research. New revelations about the long QT syndrome. NEJM. 1995;333:384-385.
44. 44. Roden DM, Lazzara R, Rosen M, et al., for the SADS Foundation Task Force on LQTS. Multiple mechanisms in the long QT syndrome. Current knowledge, gaps, and future directions. Circulation. 1996;94:1996-2012.
45. + channel α-subunit in hyperkalaemic periodic paralysis. Nature. 1991;354:387-389.
46. 46. Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome in patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for specific gene therapy. Circulation. 1995;92:3381-3386.
47. 47. Bean BP. Classes of calcium channels in vertebrate cells. Ann Rev Physiol. 1989;51:367-384.
48. 48. Tsien RW, Tsien RY. Calcium channels, stores, and oscillations. Ann Rev Cell Biol. 1990;6:715-760.
49. 49. Sperelakis N. Properties of calcium channels in cardiac and vascular smooth muscle. Mol Cell Pharm. 1990;99:97-109.
50. 50. McDonald TF, Pelzer S, Trautwein W, Pelzer D. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev. 1994;72:365-507.
51. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology. 1993;32:1075-1088.
52. 52. Brust PF, Simerson S, McCue AF, et al. Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology. 1993;32:1089-1102.
53. 53. Bogdanov KY, Ziman BD, Spurgeon HA, Lakatta EG. L- and T-type calcium currents differ in finch and rat ventricular cardiomyocytes. J Mol Cell Cardiol. 1995;27:2581-2593.
54. 2+ current blocker in single heart cells. Am J Physiol 1992;262:H463-H471.
55. 55. Beam KG, Knudson CM. Effect of postnatal development on calcium currents and slow charge movement in mammalian skeletal muscle. J Gen Physiol. 1988;91:799-815.
56. 56. Gonoi T, Hasegawa S. Post-natal disappearance of transient calcium channels in mouse skeletal muscle: effects of denervation and culture. J Physiol (Lond). 1988;401:617-637.
57. 57. Kostyuk PG. Diversity of calcium channels in cellular membranes. Neuroscience. 1989;28:253-261.
58. 58. McCobb DP, Best PM, Beam KG. Development alters the expression of calcium currents in chick limb motoneuron. Neuron. 1989; 2:1633-1643.
59. 59. Xu X, Best PM. Postnatal changes in T-type calcium current density in rat atrial myocytes. J Physiol (Lond). 1992;454:657-672.
60. 2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res. 1996;79:14-19.
61. 61. Xu X, Best PM. Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors. Proc Nat Acad Sci (USA). 1990;87:4655-4659.
62. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res. 1993;73: 777-782.
63. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res. 1994; 75:149-155.
64. 2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts. Am J Physiol. 1993;265:C1239-C1246.
65. 65. Furukawa T, Ito H, Niita J, et al. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ Res. 1992;71:1242-1253.
66. 66. Schmitt R, Clozel J-P, Iberg N, Bühler FR. Mibefradil prevent neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscleros Thromb Vasc Biol. 1995;15:1161-1165.
67. 67. Chandy KG. Simplified gene nomenclature. Nature. 1991;352:26. Letter.
68. 68. Agnew WS. A Rosetta stone for K channels. Nature. 1988;331: 114-115.
69. 69. Aldrich RW. Potassium channels. Mixing and matching. Nature. 1990;345:475-476.
70. 70. Katz AM, Katz PB. Homogeneity out of heterogeneity. Circulation. 1989;79:712-717.
71. 71. Keating MT. Genetic approaches to cardiovascular disease. Supravalvular stenosis, Williams syndrome, and long-Q-T syndrome. Circulation. 1995;92:142-147.
72. 72. Benson DW, MacRae CA, Vesely MR, et al. Missense mutation in the pore region of HERG causes familial long Q-T syndrome. Circulation. 1996;93:1791-1795.
73. 73. Dausse E, Berthet M, Denjoy I, et al. A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol. 1996;28:1609-1615.
74. ks cardiac potassium current. Nature. 1996;384:78-80.
75. ks potassium channel. Nature. 1996;384:80-83.
76. 76. Attali B. A new wave for heart rhythms. Nature. 1996;384:24-25.
77. 77. Timpe LC, Schwartz TL, Tempel BL, et al. Expression of functional potassium channels from Shaker cDNA in Xenopus oocytes. Nature. 1988;331:143-145.
78. + channels conserved in flies, mice and humans. Trends Neurosci. 1992;15:161-166.
79. 79. Lazdunski M. Potassium channels: structure-function relationships, diversity and pharmacology. Cardiovasc Drugs Ther. 1992; 6:313-319.
80. 80. Ho K, Nichols CG, Lederer WJ, et al. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature. 1993;362:31-38.
81. 81. Kubo Y, Baldwin TJ, Jan YN, Jan L. Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature. 1993;362:127-132.
82. 82. Carmeliet E. Potassium channels in cardiac cells. Cardiovasc Drugs Ther. 1992;6:305-312.
83. Ks contributes to the longer action potential of the M cell. Circ Res. 1995;76:351-365.
84. 84. Furukawa T, Myerburg RJ, Furukawa N, et al. Differences in transient outward currents of feline endocardial and epicardial myocytes. Circ Res. 1990;67:1287-1291.
85. 85. Fedida D, Giles WR. Regional variations in action potentials and transient outward current in myocytes isolated from rabbit left ventricle. J Physiol (Lond). 1991;442:191-209.
86. 86. Liu D-W, Gintant Gam Antzelevitch C. Ionic basis for electrophysiological differences among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res. 1993;72:671-687.
87. 87. Katz AM. T-wave "memory:" possible causal relationship to stress-induced changes in cardiac ion channels. J Cardiovasc Electrophys. 1992;3:150-159.
88. 88. del Balzo U, Rosen MR. T-wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine: implications with respect to cardiac "memory." Circulation. 1992;85:1464-1472.
89. 89. Ricard P, Yu H, Danilo P et al. The role of the renin-angiotensin II system in cardiac T wave memory. Circulation. 1996;94(suppl I): 1-6.
90. 90. Katz AM, Messineo FC. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res. 1981;48:1-16.
91. +-channel proteins. Nature. 1995;374:135-141.
92. 92. Pongs O. Molecular biology of voltage-dependent potassium channels. Physiol Rev. 1992;72:S69-S-88.
93. + channels in the heart. Fund Clin Pharmacol. 1994;8:108-116.
94. 94. Jan LY, Jan YN. Potassium channels and their evolving gates. Nature. 1994;371:119-122.
95. 95. Smith PL, Baukrowitz T, Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature. 1996;379: 833-835.
96. 96. Miller C. The inconstancy of the human heart. Nature. 1996;379: 767-768.
97. + channels. Trends Pharm Sci. 1993;14:320-323.
98. + channel from human atrium. Circulation. 1995;76:343-350.
99. 99. Takumi T, Ohkubo H, Nakanishi S. Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science. 1988;242:1042-1045.
100. 100. Takumi T, Moriyoshi K, Aramori I, et al. Alteration of channel activities and gating by mutations of slow Isk potassium channel. J Biol Chem. 1991;266:22192-22198.
101. - channels. Nature. 1993;356:850-852.
102. 102. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the anti-arrhythmic agent moricizine on survival after myocardial infarction. NEJM. 1992;327:227-233.
103. 103. Ten Eick RE, Zhang Z, Harvey RD, Bassett AL. Enhanced functional expression of transient outward current in hypertrophied feline myocytes. Cardiovasc Drugs Ther. 1993;7:611-619.
104. 104. DeFelice LJ, Isaac, A. Chaotic states in a random world: relationship between the nonlinear differential equations of excitability and the stochastic properties of ion channels. J Statistical Phys. 1993;1/2:339-353.
105. 105. Elbert T, Ray WJ, Kowalik ZJ, et al. Chaos and physiology: deterministic chaos in excitable cell assemblies. Physiol Rev. 1994;74:1-47.
106. 106. Gilman AG, Rall TW, Nies AS, Taylor P. The Pharmacological Basis of Therapeutics. New York: Pergamon; 1990.
107. 107. Herbette LG, Trumbore M, Chester DW, Katz AM. Possible molecular basis for the pharmacodynamics of three membrane active drugs: propranolol, nimodipine, amiodarone. J Mol Cell Cardiol. 1988;20:373-378.
108. 108. Herbette LG, Mason RP. Techniques for determining membrane and drug-membrane structures: a reevaluation of the molecular and kinetic basis for the binding of lipid-soluble drugs to their receptors in heart and brain. In: Fozzard H, Haber E, Katz A, et al, eds. The Heart and Cardiovascular System. 2nd ed. New York: Raven Press; 1992:417-462.
109. 109. Herbette LG, Katz AM, Sturtevant JM. Comparisons of the interaction of propranolol and timolol with model and biological membrane systems. Mol Pharmacol. 1983;24:259-269.
110. + channels. Proc Nat Acad Sci. 1996;93:9270-9275.
111. 111. Striessig J, Scheuffauer F, Mitterdorfer J, et al. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. J Biol Chem. 1990;265:363-370.
112. 2+-antagonists. Trends Pharm Sci. 1992;13:256-262.
113. 113. Tamkun MM, Knittle TJ, Deal KK, et al. Molecular physiology of voltage-gated potassium and sodium channels: ion channel diversity within the cardiovascular system. In: Spooner PM, Brown AM, eds. Ion Channels in the Cardiovascular System. New York: Futura; 1994:288-316.
114. 114. Rasmusson RL, Campbell DL, Qu Y, Strauss HC. Conformation-dependent drug binding to cardiac potassium channels. In: Spooner PM, Brown AM, eds. Ion Channels in the Cardiovascular System. New York: Futura; 1994:387-414.
115. 115. Striessnig J, Hering S, Berger W, et al. Calcium antagonist binding domains of L-type calcium channels. In: Spooner PM, Brown AM, eds. Ion Channels in the Cardiovascular System. New York Futura; 1994:441-458.
116. 116. Hondeghem L, Katzung BG. Time- and voltage-dependent interaction of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977;472:373-398.
117. 117. Hondeghem L, Katzung BG. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann Rev Pharmacol Toxicol. 1984;24:387-423.
118. max) of action potential upstroke of guinea pig papillary muscle. Circ Res. 1976;38:464-469.
119. 119. Weirich J, Antoni H. Differential analysis of the frequency-dependent effects of class I antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy. J Cardiovasc Pharm. 1990;15:998-1009.
120. 120. Scholz H. Classification and mechanism of action of antiarrhythmic drugs. Fund Clin Pharmacol. 1994;8:385-390.
121. 121. Hess P, Lansman JB, Tsien RW. Different modes of Ca channel gating behaviour favored by dihydropyridine Ca channel agonists and antagonists. Nature. 1984;311:538-544.
122. 122. Vaughan Williams EM. Classification of antiarrhythmic actions. In: Vaughan Williams EM, Campbell TJ, eds. Handbook of Experimental Pharmacology. Antiarrhythmic Drugs. Berlin: Springer-Verlag; 1989;89:45-57.
123. 123. Nattel S. Antiarrhythmic drug classifications. A critical appraisal of their history, present status and clinical review. Drugs. 1991;41: 672-701.
124. 124. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation. 1991;84:1831-1851.
125. 125. Katz AM. Introduction: Ion channels and cardiology. The need for bridges across a widening boundary. In: Spooner PM, Brown AM, eds. Ion Channels in the Cardiovascular System. New York: Futura; 1994:xxiii-xxix.